4d Medicine Ltd

4D Medicine Ltd from Nottingham UK: a small, active company founded six years ago, employs nine people, and holds £495,361 in assets. It’s a real address, managed by five directors, but curiously, there are no listed owners. The company irregularly imports machinery, boilers, and mechanical appliances—parts, with the last import operation recorded one month ago.

The company's website reveals a focus on bioabsorbable medical devices, a once-in-a-generation innovation set to revolutionise the future of the field. Professor Andrew Dove, a world leader in bioabsorbable polymer chemistry, has developed 4Degra, a patented implantable medical polymer. 4D Medicine is focused on two key areas: biomaterials and medical devices. The company is currently pursuing FDA approval for its first product, a bioabsorbable interference screw, and actively seeks partnerships with medical device organisations. It's a small company, meeting two of three conditions for classification: turnover under £10.2 million, balance sheet total under £5.1 million, and fewer than 50 employees.

Financially, 4D Medicine Ltd presents a mixed picture. Cash bank on hand decreased by 7.7% to £360,000, and current assets dropped 8.8% to £500,000. However, creditors surged by a significant 170% to £110,000—a possible sign of increased investment or supplier credit. Equity plummeted 66% to -£2.2 million, a worrying trend. Trade debtors decreased by 11%, suggesting improved collection of payments. The company’s small size and lack of an auditor (likely exempt) mean the figures are unaudited.

It seems like 4D Medicine Ltd is navigating some financial challenges, but its focus on innovative medical technology and active pursuit of partnerships could position it for future growth.

Registered in England/Wales under the registration number 11598297, with a registered address at NG90 6BH, England, Nottingham, Room 134 D6 West Building Medicity Nottingham, 1 Thane Road.

WARNING:The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.